CT Coronary Angiography in Acute Chest Pain

Definition

CT coronary angiography (CTCA) in acute chest pain is the use of a noninvasive coronary CT angiogram, usually after myocardial infarction has been ruled out by high-sensitivity troponin, to detect coronary artery disease, guide preventive therapy and triage further investigation. The clinical question is not whether CTCA can image the coronary tree — it can, reliably, in most patients — but whether adding it to a troponin-based pathway changes the outcomes that matter: myocardial infarction, cardiac death and downstream care. (sources/TARGET-CTCA-NEJM-2026, rating: high)

Key Concepts

Rationale and Risk Stratification

The TARGET-CTCA Trial

Element Detail
Population 3,170 adults with suspected ACS, MI ruled out, maximum high-sensitivity troponin >5 ng/L and below the sex-specific 99th percentile; median age 61; 30.2% women
Intervention Outpatient CTCA-guided care plus standard care versus standard care alone
CTCA delivery 92.1% underwent CTCA, median 22 days after randomization
CT findings Normal 31.8%, nonobstructive disease 42.5%, obstructive disease 22.6%
Primary outcome Myocardial infarction or cardiac death at a median 3.0 years: 7.1% versus 7.3%; adjusted HR 0.95 (95% CI 0.73–1.23); P=0.71
Secondary outcomes MI 5.9% versus 6.3%; cardiac death 1.4% versus 1.7%; all-cause death 4.6% versus 6.1% (not multiplicity-adjusted)
Care change Antiplatelet use 42.4% versus 32.8% and statin use 63.4% versus 48.5% at 90 days
Safety CTCA-related adverse events 0.4%, all mild

(sources/TARGET-CTCA-NEJM-2026, rating: high)

Detection versus Outcome Benefit

Subgroups and the Risk-Score Paradox

Guideline Context

Relationship to Other CTCA Strategies

Contradictions / Open Questions

Connections

Sources